- ISIN
- US8835561023
- CUSIP
- 883556102
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- IPO Date
- Jan 13, 1978
Highlights
- Market Cap
- $179.82B
- Enterprise Value
- $222.81B
- EPS (TTM)
- $18.22
- PE Ratio
- 26.46
- Total Revenue (TTM)
- $45.20B
- Gross Profit (TTM)
- $17.81B
- EBITDA (TTM)
- $11.16B
- Year Range
- $385.46 - $643.99
- Target Price
- $665.20
- ROA (TTM)
- 6.05%
- ROE (TTM)
- 13.21%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
TMO Performance Chart
Thermo Fisher Scientific Inc. (TMO) is down 16.7% since the beginning of the year. At $482 per share, TMO is trading 25.1% below its 52-week high of $644. Investors who bought $1,000 worth of TMO shares 5 years ago would now be looking at an investment worth $1,097.
Loading charts...
Returns By Period
Thermo Fisher Scientific Inc. (TMO) has returned -16.72% so far this year and 22.04% over the past 12 months. Over the last ten years, TMO has returned 12.49% per year, falling short of the S&P 500 Index benchmark, which averaged 13.75% annually.
Thermo Fisher Scientific Inc.
- 1D
- -2.42%
- 1M
- 2.74%
- YTD
- -16.72%
- 6M
- -16.79%
- 1Y
- 22.04%
- 3Y*
- -2.20%
- 5Y*
- 1.87%
- 10Y*
- 12.49%
Benchmark (S&P 500 Index)
- 1D
- 0.13%
- 1M
- 5.25%
- YTD
- 11.16%
- 6M
- 11.43%
- 1Y
- 28.20%
- 3Y*
- 21.12%
- 5Y*
- 12.66%
- 10Y*
- 13.75%
TMO Monthly Returns History
Based on dividend-adjusted daily data since Sep 1, 1987, TMO's average daily return is +0.06%, while the average monthly return is +1.29%. At this rate, an investment would double in approximately 4.5 years.
Historically, 57% of months were positive and 43% were negative. The best month was Oct 1998 with a return of +32.4%, while the worst month was Oct 1987 at -39.6%. The longest winning streak lasted 12 consecutive months, and the longest losing streak was 7 months.
On a daily basis, TMO closed higher 49% of trading days. The best single day was Oct 30, 1987 with a return of +17.7%, while the worst single day was Oct 26, 1987 at -18.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0.14% | -9.94% | -5.58% | -2.56% | 2.83% | -2.12% | -16.72% | ||||||
| 2025 | 14.90% | -11.51% | -5.85% | -13.79% | -6.10% | 0.76% | 15.35% | 5.35% | -1.47% | 16.98% | 4.13% | -1.85% | 11.78% |
| 2024 | 1.54% | 5.79% | 2.00% | -2.15% | -0.13% | -2.57% | 10.91% | 0.28% | 0.63% | -11.68% | -3.05% | -1.70% | -1.72% |
| 2023 | 3.57% | -5.01% | 6.46% | -3.73% | -8.37% | 2.68% | 5.16% | 1.54% | -9.08% | -12.13% | 11.46% | 7.14% | -3.36% |
| 2022 | -12.88% | -6.42% | 8.64% | -6.39% | 2.65% | -4.22% | 10.15% | -8.87% | -6.94% | 1.34% | 9.00% | -1.65% | -17.29% |
| 2021 | 9.43% | -11.70% | 1.46% | 3.03% | -0.16% | 7.51% | 7.05% | 2.77% | 3.00% | 10.81% | -0.04% | 5.48% | 43.54% |
Benchmark Metrics
Thermo Fisher Scientific Inc. has an annualized alpha of 7.39%, beta of 0.87, and R2 of 0.29 versus S&P 500 Index. Calculated based on daily prices since September 02, 1987.
- This stock captured 126.56% of S&P 500 Index gains and 109.77% of its losses - amplifying both gains and losses, but participating more in upside than downside.
- R2 of 0.29 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 7.39%
- Beta
- 0.87
- R²
- 0.29
- Upside Capture
- 126.56%
- Downside Capture
- 109.77%
Return for Risk
Risk / Return Rank
TMO ranks 58 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Thermo Fisher Scientific Inc. (TMO) and compare them to S&P 500 Index.
| TMO | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.72 | 2.39 | -1.67 |
Sortino ratioReturn per unit of downside risk | 1.25 | 3.25 | -2.01 |
Omega ratioGain probability vs. loss probability | 1.15 | 1.43 | -0.28 |
Calmar ratioReturn relative to maximum drawdown | 0.71 | 3.11 | -2.41 |
Martin ratioReturn relative to average drawdown | 1.61 | 14.38 | -12.77 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Thermo Fisher Scientific Inc. provided a 0.37% dividend yield over the last twelve months, with an annual payout of $1.76 per share. The company has been increasing its dividends for 13 consecutive years.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $1.76 | $1.72 | $1.56 | $1.40 | $1.20 | $1.04 | $0.88 | $0.76 | $0.68 | $0.60 | $0.60 | $0.60 |
Dividend yield | 0.37% | 0.30% | 0.30% | 0.26% | 0.22% | 0.16% | 0.19% | 0.23% | 0.30% | 0.32% | 0.43% | 0.42% |
Monthly Dividends
The table displays the monthly dividend distributions for Thermo Fisher Scientific Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.47 | $0.00 | $0.00 | $0.00 | $0.47 | ||||||
| 2025 | $0.00 | $0.00 | $0.43 | $0.00 | $0.00 | $0.43 | $0.00 | $0.00 | $0.43 | $0.00 | $0.00 | $0.43 | $1.72 |
| 2024 | $0.00 | $0.00 | $0.39 | $0.00 | $0.00 | $0.39 | $0.00 | $0.00 | $0.39 | $0.00 | $0.00 | $0.39 | $1.56 |
| 2023 | $0.00 | $0.00 | $0.35 | $0.00 | $0.00 | $0.35 | $0.00 | $0.00 | $0.35 | $0.00 | $0.00 | $0.35 | $1.40 |
| 2022 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.30 | $1.20 |
| 2021 | $0.00 | $0.00 | $0.26 | $0.00 | $0.00 | $0.26 | $0.00 | $0.00 | $0.26 | $0.00 | $0.00 | $0.26 | $1.04 |
Dividend Yield & Payout
Dividend Yield
Thermo Fisher Scientific Inc. has a dividend yield of 0.37%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
Thermo Fisher Scientific Inc. has a payout ratio of 9.46%, which is below the market average. This means Thermo Fisher Scientific Inc. returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Thermo Fisher Scientific Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Thermo Fisher Scientific Inc. was 71.16%, occurring on Apr 15, 1999. Recovery took 1765 trading sessions.
The current Thermo Fisher Scientific Inc. drawdown is 26.87%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
1999 bear market1999 | -71.16%Apr 1999 | 1y 3mo | 7y 8d | 8y 3moJan 1998 - Apr 2006 |
Black Monday1987 | -56.10%Oct 1987 | 1mo 26d | 1y 6mo | 1y 8moSep 1987 - May 1989 |
Financial crisis2007–2009 | -53.91%Nov 2008 | 3mo 4d | 2y 5mo | 2y 9moAug 2008 - May 2011 |
1990 bear market1990 | -41.90%Oct 1990 | 1y 7d | 6mo 29d | 1y 7moOct 1989 - May 1991 |
2025 selloff2025 | -40.95%Jun 2025 | 3y 5mo | — | 4y 5moJan 2022 - now |
Drawdown Indicators
| TMO | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -71.16% | -56.78% | -14.38% |
Max Drawdown (1Y)Largest decline over 1 year | -31.38% | -9.10% | -22.28% |
Max Drawdown (3Y)Largest decline over 3 years | -37.28% | -18.90% | -18.38% |
Max Drawdown (5Y)Largest decline over 5 years | -40.95% | -25.43% | -15.52% |
Max Drawdown (10Y)Largest decline over 10 years | -40.95% | -33.92% | -7.03% |
Current DrawdownCurrent decline from peak | -26.87% | 0.00% | -26.87% |
Average DrawdownAverage peak-to-trough decline | -18.01% | -10.72% | -7.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.71% | 1.97% | +11.74% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Thermo Fisher Scientific Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Thermo Fisher Scientific Inc. is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for TMO, comparing it with other companies in the Diagnostics & Research industry. Currently, TMO has a P/E ratio of 26.5. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for TMO relative to other companies in the Diagnostics & Research industry. Currently, TMO has a P/S ratio of 4.0. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for TMO in comparison with other companies in the Diagnostics & Research industry. Currently, TMO has a P/B value of 3.5. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with TMO
Add Thermo Fisher Scientific Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with TMO